cdmo.directory
← Compare landing

Artis BioSolutions vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/artis-biosolutions/ubrigene

CategoryArtis BioSolutionsuBriGene
Listed sitecdmoboth
SummaryIntegrated CDMO platform combining proprietary enzymatic synthetic DNA production with advanced therapy development and GMP manufacturing for mRNA, gene editing, viral vectors, cell therapies, and vaccines.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services
  • Process Development
  • Technology Transfer
  • mRNA Manufacturing
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Vaccine Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • mRNA
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
  • Vaccine
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
Locations
  • Headquarters & Manufacturing, Watertown, MA, United States
  • Manufacturing, Bilbao, Spain
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
CertificationsData not yet provided.
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.